China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals announced a 1-for-100 share consolidation of its Class A ordinary shares, effective at market open on October 26, 2026. Shares outstanding fall from roughly 68.7 million to about 686,775, with options, warrants, and other rights adjusted proportionately; the ticker and CUSIP change, but Class B shares are unaffected.
Key figures
- Reverse split ratio
- 1-for-100
- Shares outstanding after
- 686775
- Shares outstanding before
- 68677500
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.